These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6328337)

  • 1. Renal excretion of an angiotensin I converting enzyme inhibitor (SA-446) in dogs.
    Abe Y; Okahara T; Miura K; Yukimura T; Takada T; Iwatani T; Iso T; Yamamoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):356-9. PubMed ID: 6328337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiotensin I-converting enzyme inhibitor (SA-446) on renal function in dogs.
    Takada T; Yamamoto K; Fujioka S; Tamaki T; Fukui K; Abe Y
    Jpn J Pharmacol; 1985 Jun; 38(2):227-30. PubMed ID: 2993720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of SA-446, an angiotensin-converting enzyme inhibitor, on renal function in anesthetized dogs: special reference to arachidonic acid metabolites.
    Miura K; Yukimura T; Imanishi M; Okahara T; Abe Y; Yamamoto K
    J Cardiovasc Pharmacol; 1985; 7(1):102-7. PubMed ID: 2580127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on mechanisms of antinephritic action of SA-446 an angiotensin I converting enzyme inhibitor (1). A comparison with actions of spironolactone, kallidinogenase and saralasin.
    Suzuki Y; Ito M; Saito N
    Jpn J Pharmacol; 1986 Dec; 42(4):465-75. PubMed ID: 3027437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an orally active converting enzyme inhibitor (YS-980) on renal function in dogs.
    Abe Y; Miura K; Imanishi M; Yukimura T; Komori T; Okahara T; Yamamoto K
    J Pharmacol Exp Ther; 1980 Jul; 214(1):166-70. PubMed ID: 6156237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
    Nishimura K; Miyazaki M; Okunishi H; Toda N
    Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
    Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species difference of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinec arb oxylic acid (SA446) in inhibition of angiotensin converting enzyme.
    Nakata K; Iwatani T; Horiuchi M; Kito H; Yamauchi H; Iso T
    Jpn J Pharmacol; 1986 Mar; 40(3):367-72. PubMed ID: 3012163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Schaz K; Vescel P; Bönner G; Rascher W; Ganten D
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():157s-160s. PubMed ID: 232020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats.
    Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K
    Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
    Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
    Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
    Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive mechanism of an angiotensin converting enzyme inhibitor, SA446, in dogs.
    Nishimura K; Okunishi H; Miyazaki M
    Bull Osaka Med Coll; 1989 Nov; 35(1-2):29-37. PubMed ID: 2486241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin converting enzyme inhibitors MK 421, SA 446 and captopril on renal prostaglandin E and kinins in conscious normotensive rats.
    Yasujima M; Abe K; Tanno M; Kohzuki M; Kasai Y; Kanazawa M; Omata K; Sato M; Takeuchi K; Yoshinaga K
    Clin Exp Hypertens A; 1987; 9(2-3):401-4. PubMed ID: 3038402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446.
    Mendelsohn FA; Csicsmann J; Hutchinson JS
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():277s-280s. PubMed ID: 6172236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
    Nakata K; Takada T; Yamauchi H; Iso T
    Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of angiotensin converting enzyme by (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid, SA 446].
    Horiuchi M; Terashima T; Fujimura K; Shimokawa K; Iso T
    Yakugaku Zasshi; 1984 Dec; 104(12):1257-62. PubMed ID: 6099853
    [No Abstract]   [Full Text] [Related]  

  • 20. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
    Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
    Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.